Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Multiple Trauma D009104 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Contracture D003286 3 associated lipids
Toxemia D014115 3 associated lipids
Bronchial Diseases D001982 3 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Brain Injuries D001930 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Spasm D013035 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Colonic Diseases D003108 5 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Strongylida Infections D017206 5 associated lipids
Heart Injuries D006335 6 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Sneezing D012912 6 associated lipids
Thrombophilia D019851 6 associated lipids
Gliosis D005911 6 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Ear Diseases D004427 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Klebsiella Infections D007710 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Conjunctivitis D003231 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Mucositis D052016 7 associated lipids
Bronchiectasis D001987 7 associated lipids
Agranulocytosis D000380 7 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Cholecystitis D002764 8 associated lipids
Arthus Reaction D001183 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Lupus Nephritis D008181 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Balestrieri ML et al. Types of purinoceptors and phospholipase A2 involved in the activation of the platelet-activating factor-dependent transacetylase activity and arachidonate release by ATP in endothelial cells. 1998 Prostaglandins Other Lipid Mediat. pmid:9990678
Travers JB et al. Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. 1998 Prostaglandins Other Lipid Mediat. pmid:9990675
Wang MM et al. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. 1999 Biochim. Biophys. Acta pmid:9989266
Snyder F The ether lipid trail: a historical perspective. 1999 Biochim. Biophys. Acta pmid:9989259
Syrbu SI et al. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils. 1999 J. Immunol. pmid:9973512
Hayani KC et al. Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children. 1999 J. Infect. Dis. pmid:9952364
Tamaoki J et al. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. 1999 Am. J. Physiol. pmid:9950898
Piwinski JJ et al. Dual antagonists of platelet activating factor and histamine. 3. Synthesis, biological activity and conformational implications of substituted N-acyl-bis-arylcycloheptapiperazines. 1998 Bioorg. Med. Chem. Lett. pmid:9934454
Lee LW et al. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation. 1999 Eur. J. Pharmacol. pmid:9932729
Ohshige A et al. Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses. 1999 Obstet Gynecol pmid:9932551
Bazan NG The neuromessenger platelet-activating factor in plasticity and neurodegeneration. 1998 Prog. Brain Res. pmid:9932449
McCall MR et al. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. 1999 Biochim. Biophys. Acta pmid:9931415
Onorato JM et al. Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease. 1998 Ann. N. Y. Acad. Sci. pmid:9928437
Berger A et al. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. 1999 Am. J. Respir. Crit. Care Med. pmid:9927381
Toledano BJ et al. Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor. 1999 Cell. Immunol. pmid:9918687
Gedeborg R and Wiklund L Experimental model of cardiovascular post-resuscitation syndrome--no effect of platelet activating factor antagonism. 1998 Oct-Nov Resuscitation pmid:9918458
Stafforini DM and Tjoelker LW Human plasma platelet-activating factor acetylhydrolase. 1999 Methods Mol. Biol. pmid:9918011
Siddiqui RA et al. Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes. 1999 J. Immunol. pmid:9916736
Zhang Y et al. RGS16 attenuates galphaq-dependent p38 mitogen-activated protein kinase activation by platelet-activating factor. 1999 J. Biol. Chem. pmid:9915820
Qu XW et al. The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat. 1999 Gut pmid:9895379
Tetta C et al. The role of platelet-activating factor in the haemoincompatibility of haemodialytic treatments. 1998 Int J Artif Organs pmid:9894743
Yamaguchi S et al. Effect of Y-24180, an antagonist at platelet-activating factor (PAF) receptors, on IgE-mediated cutaneous reactions in mice. 1998 Inflamm. Res. pmid:9892046
Akiba S et al. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. 1998 Biochem. Mol. Biol. Int. pmid:9891858
Longphre M et al. Ozone-induced pulmonary inflammation and epithelial proliferation are partially mediated by PAF. 1999 J. Appl. Physiol. pmid:9887149
Harris NR et al. Influence of arteriovenular pairing on PAF-induced capillary filtration. 1999 Am. J. Physiol. pmid:9887023
Tsuruta R et al. Soluble vascular cell adhesion molecule (VCAM)-Fc fusion protein induces leukotriene C4 secretion in platelet-activating factor-stimulated eosinophils. 1999 J. Leukoc. Biol. pmid:9886248
Chang FR et al. Two new 7-dehydroaporphine alkaloids and antiplatelet action aporphines from the leaves of Annona purpurea. 1998 Phytochemistry pmid:9883592
Nakano T et al. Roxythromycin reinforces epithelial defence function in rabbit trachea. 1998 Acta Otolaryngol Suppl pmid:9879427
Todoroki H et al. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils. 1998 J. Surg. Res. pmid:9878306
Kawasaki Y et al. Specific detections of the early process of the glycation reaction by fructose and glucose in diabetic rat lens. 1998 FEBS Lett. pmid:9877177
Dhainaut JF et al. Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. 1998 Crit. Care Med. pmid:9875905
Zhang J et al. Strategies of myocardial protection for operation in chronic model of cyanotic heart disease. 1998 Ann. Thorac. Surg. pmid:9875743
Huh H et al. PAF antagonistic activity of 2-hydroxy-3-methoxybenzoic acid glucose ester from Gentiana scabra. 1998 Arch. Pharm. Res. pmid:9875472
Dutra PM et al. A novel ecto-phosphatase activity of Herpetomonas muscarum muscarum inhibited by platelet-activating factor. 1998 Biochem. Biophys. Res. Commun. pmid:9875238
Chen JZ et al. A 3D-QSAR study on ginkgolides and their analogues with comparative molecular field analysis. 1998 Bioorg. Med. Chem. Lett. pmid:9871752
Powell WS et al. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. 1999 Am. J. Respir. Cell Mol. Biol. pmid:9870930
pmid:9870780
Venugopalan CS et al. Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease. 1998 Vet. Res. Commun. pmid:9868763
Kaminskaia GO et al. [Oxidative metabolic changes, antioxidantion, and platelet activation rat phagocytes during development of experimental specific tuberculous changes]. 1998 Probl Tuberk pmid:9866402
Pesce L et al. Effect of Fenoterol on PAF-induced lung edema in isolated and perfused rabbit lungs. 1998 Respir Physiol pmid:9865589
Hammer C et al. Xenogeneic rejection mechanisms shown by intravital microscopy. 1998 Transplant. Proc. pmid:9865335
Jeanneton O et al. Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig. 1998 Gut pmid:9863481
Nagai H et al. Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice. 1999 J. Pharmacol. Exp. Ther. pmid:9862751
Egesten A and Malm J Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C. 1998 Allergy pmid:9860239
Chihara J et al. Inhibitory effect of ibudilast (KC-404) on the expression of the beta2 integrin family on an eosinophilic cell line (EoL-1). 1998 Ann. Allergy Asthma Immunol. pmid:9860039
Sharif NA et al. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. 1998 Invest. Ophthalmol. Vis. Sci. pmid:9856766
Stamatiou P et al. 5-oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in Brown Norway rats. 1998 J. Clin. Invest. pmid:9854052
Gardner JP and Zhang L Glucocorticoid modulation of Ca2+ homeostasis in human B lymphoblasts. 1999 J. Physiol. (Lond.) pmid:9852321
Reiner O and Sapir T Abnormal cortical development; towards elucidation of the LIS1 gene product function (review). 1998 Int. J. Mol. Med. pmid:9852306
Reverdiau-Moalic P et al. Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathway. 1998 J. Lab. Clin. Med. pmid:9851744